This compound is a protected nucleoside derivative used as an intermediate in the solid-phase synthesis of oligonucleotides. Its structure features a uridine base with an acetamide group and a 4,4′-dimethoxytrityl (DMT) protecting group on the 5′-hydroxyl, along with a 2′-O-methyl modification, making it suitable for RNA-based oligonucleotide assembly.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 199593-08-3
N-Acetyl-5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-(tert-butyl(dimethyl)silyl)cytidine
nucleoside protecting group intermediate
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
DMT-N4-Acetyl-2'-Deoxycytidine
Pharmaceutical intermediate for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N6-BENZOYL-2'-O-METHYL-ADENOSINE
nucleoside intermediate for oligonucleotide synthesis
1-Bromo-4-chloro-2-fluorobenzene
Pharmaceutical intermediate
4-[[[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyl]amino]benzoic acid
Pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
FINUHOJILDNELQ-PMFUCWTESA-N
CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)OC